Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Remo

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|November 11, 2016
The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) applied to pivotal phase III randomized-controlled trials of tyrosine kinase inhibitors in first-line for advanced non-small cell lung cancer with activating epidermal growth factor receptor mutationsJacopo Giuliani, Andrea Remo, Andrea Bonetti
Pathology Research International|August 14, 2012
Genetic and epigenetic events generate multiple pathways in colorectal cancer progressionMassimo Pancione, Andrea Remo, Vittorio Colantuoni
Trends in Molecular Medicine|April 12, 2020
The Centrosome Linker and Its Role in Cancer and Genetic DisordersAndrea Remo, Xue Li, Elmar Schiebel, et al.
Tumori|May 9, 2015
Primary TKI resistance in advanced non-small cell lung cancer with EGFR mutation: an open questionJacopo Giuliani, Salvatore Martelli, Andrea Remo, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 24, 2015
p16 Expression in Prostate Cancer and Nonmalignant Lesions: Novel Findings and Review of the LiteratureAndrea Remo, Massimo Pancione, Caterina Zanella, et al.
Cancers|August 3, 2019
Immune Resistance and EGFR Antagonists in Colorectal CancerGuido Giordano, Andrea Remo, Almudena Porras, et al.
Tumori|May 24, 2014
KRAS mutations and M2PK upregulation in stool samples from individuals with positive fecal occult blood tests screened for colorectal cancerPaolo Battaglia, Elisabetta Baritono, Andrea Remo, et al.
Breast Cancer Research and Treatment|April 26, 2007
Risk of neoplastic transformation in asymptomatic radial scar. Analysis of 117 casesErminia Manfrin, Andrea Remo, Francesca Falsirollo, et al.
La Radiologia Medica|January 27, 2006
Imaging of the male breastElisabetta Jellici, Roberto Malagò, Andrea Remo, et al.
Tumori|June 30, 2026
Quality indicators in identification and care of patients with genetic predisposition to cancer: An AIFET proposalAndrea Remo, Maria Grazia Tibiletti, Giovan Battista Rossi, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Expert Review of Pharmacoeconomics & Outcomes Research|November 11, 2016
The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) applied to pivotal phase III randomized-controlled trials of tyrosine kinase inhibitors in first-line for advanced non-small cell lung cancer with activating epidermal growth factor receptor mutationsJacopo Giuliani, Andrea Remo, Andrea Bonetti
Pathology Research International|August 14, 2012
Genetic and epigenetic events generate multiple pathways in colorectal cancer progressionMassimo Pancione, Andrea Remo, Vittorio Colantuoni
Trends in Molecular Medicine|April 12, 2020
The Centrosome Linker and Its Role in Cancer and Genetic DisordersAndrea Remo, Xue Li, Elmar Schiebel, et al.
Tumori|May 9, 2015
Primary TKI resistance in advanced non-small cell lung cancer with EGFR mutation: an open questionJacopo Giuliani, Salvatore Martelli, Andrea Remo, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 24, 2015
p16 Expression in Prostate Cancer and Nonmalignant Lesions: Novel Findings and Review of the LiteratureAndrea Remo, Massimo Pancione, Caterina Zanella, et al.
Cancers|August 3, 2019
Immune Resistance and EGFR Antagonists in Colorectal CancerGuido Giordano, Andrea Remo, Almudena Porras, et al.
Tumori|May 24, 2014
KRAS mutations and M2PK upregulation in stool samples from individuals with positive fecal occult blood tests screened for colorectal cancerPaolo Battaglia, Elisabetta Baritono, Andrea Remo, et al.
Breast Cancer Research and Treatment|April 26, 2007
Risk of neoplastic transformation in asymptomatic radial scar. Analysis of 117 casesErminia Manfrin, Andrea Remo, Francesca Falsirollo, et al.
La Radiologia Medica|January 27, 2006
Imaging of the male breastElisabetta Jellici, Roberto Malagò, Andrea Remo, et al.
Tumori|June 30, 2026
Quality indicators in identification and care of patients with genetic predisposition to cancer: An AIFET proposalAndrea Remo, Maria Grazia Tibiletti, Giovan Battista Rossi, et al.
Pageof 8